Home / Market News / $HSTM
fiscal.ai Corporate Catalyst Impact 65/100 ● negative

Craig-Hallum Downgrades HealthStream to Hold

Nov 4, 2026, 2:05 PM UTC · Primary ticker $HSTM

Craig-Hallum downgraded HealthStream (HSTM) to Hold from Buy, citing the stock's significant year-to-date appreciation leading to overvaluation. The firm set a $40 price target, suggesting limited upside potential without new product launches or acquisitions, despite the company's strategic shift towards bundled solutions.

Craig-Hallum analyst Matthew Hewitt downgraded HealthStream (HSTM) from Buy to Hold, setting a $40 price target. This downgrade is primarily due to the stock's substantial year-to-date appreciation, which has led the analyst to believe it is now overvalued. While HealthStream has strong core offerings and is strategically moving towards bundled solutions to increase contract values and renewal rates, the analyst suggests that future stock appreciation will be challenging without new product development or significant acquisitions. This news is a short-term negative catalyst for HSTM, as it signals a potential slowdown in growth expectations and could lead to selling pressure. For traders, this implies a potential ceiling on the stock's price in the near term, with a focus on future product announcements or M&A activity as potential upside drivers.

$HSTM negative Analyst downgrade due to overvaluation
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.